Stryker Corporation (SYK)vsTrinity Biotech plc (TRIB)
SYK
Stryker Corporation
$327.65
-0.26%
HEALTHCARE · Cap: $125.72B
TRIB
Trinity Biotech plc
$0.61
+0.05%
HEALTHCARE · Cap: $15.89M
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 40703% more annual revenue ($25.12B vs $61.55M). SYK leads profitability with a 12.9% profit margin vs -51.6%. TRIB appears more attractively valued with a PEG of 1.30. SYK earns a higher WallStSmart Score of 65/100 (C+).
SYK
Buy65
out of 100
Grade: C+
TRIB
Hold37
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+16.8%
Fair Value
$393.59
Current Price
$327.65
$65.94 discount
Intrinsic value data unavailable for TRIB.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 55.9% YoY
Large-cap with strong market position
Strong operational efficiency at 27.2%
Generating 1.9B in free cash flow
18.1% revenue growth
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Weak financial health signals
Smaller company, higher risk/reward
ROE of -19.1% — below average capital efficiency
Earnings declined 77.3%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : SYK
The strongest argument for SYK centers on EPS Growth, Market Cap, Operating Margin. Revenue growth of 11.4% demonstrates continued momentum.
Bull Case : TRIB
The strongest argument for TRIB centers on Revenue Growth. Revenue growth of 18.1% demonstrates continued momentum. PEG of 1.30 suggests the stock is reasonably priced for its growth.
Bear Case : SYK
The primary concerns for SYK are PEG Ratio, P/E Ratio, Piotroski F-Score.
Bear Case : TRIB
The primary concerns for TRIB are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
SYK profiles as a value stock while TRIB is a growth play — different risk/reward profiles.
SYK carries more volatility with a beta of 0.87 — expect wider price swings.
TRIB is growing revenue faster at 18.1% — sustainability is the question.
SYK generates stronger free cash flow (1.9B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (65/100 vs 37/100) and 11.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Trinity Biotech plc
HEALTHCARE · MEDICAL DEVICES · USA
Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments of the diagnostic market in the United States, Africa, Asia and Europe. The company is headquartered in Bray, Ireland.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?